STOCK TITAN

Acadia Healthcar - ACHC STOCK NEWS

Welcome to our dedicated page for Acadia Healthcar news (Ticker: ACHC), a resource for investors and traders seeking the latest updates and insights on Acadia Healthcar stock.

Overview of Acadia Healthcare (ACHC)

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a prominent provider of behavioral health and addiction treatment services, operating a vast network of facilities across the United States, the United Kingdom, and Puerto Rico. The company addresses a critical societal need by offering specialized care for individuals struggling with mental health disorders and substance abuse issues. Acadia’s services are delivered through a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and school-based programs. This multi-faceted approach allows the company to cater to a diverse range of patient needs, from acute psychiatric care to long-term recovery support.

Core Business Model and Revenue Streams

Acadia Healthcare generates the majority of its revenue from its extensive network of behavioral healthcare facilities. In the United States, the company’s acute inpatient psychiatric hospitals and specialty treatment centers are the primary revenue drivers, with payments predominantly coming from Medicaid and commercial insurance providers. In the United Kingdom, Acadia’s revenue is largely derived from contracts with the National Health Service (NHS), reflecting its integration into the public healthcare system. This diversified revenue model enables Acadia to mitigate risks associated with reliance on a single payor type or geographic region.

Industry Context and Market Position

Acadia operates within the broader behavioral healthcare industry, a sector experiencing growing demand due to increasing awareness of mental health issues and the rising prevalence of substance abuse. The company’s focus on both inpatient and outpatient services positions it to address a wide spectrum of needs, from crisis intervention to ongoing therapy. However, the industry is not without challenges, including regulatory scrutiny, workforce shortages, and competition from both large healthcare chains and local providers. Acadia differentiates itself through its scale, specialized focus, and ability to operate across multiple regulatory environments.

Specialized Services and Patient-Centric Care

Acadia Healthcare’s facilities are tailored to serve specific patient demographics, including children, teenagers, and adults. The company provides a range of services such as psychiatric care, chemical dependency treatment, and therapeutic programs integrated into educational settings. This specialization enhances Acadia’s ability to deliver high-quality, patient-centric care, addressing unique challenges faced by individuals at different stages of life.

Operational Footprint and Strategic Growth

With approximately 225 facilities and over 9,000 beds, Acadia has established a significant presence in 37 U.S. states, the United Kingdom, and Puerto Rico. This expansive footprint allows the company to leverage economies of scale while maintaining a localized approach to care delivery. Acadia’s growth strategy includes acquiring and developing new facilities, enabling it to expand its market reach and address unmet needs in behavioral healthcare.

Challenges and Opportunities

While Acadia’s scale and specialization offer competitive advantages, the company faces challenges such as regulatory compliance, public perception, and the need to sustain high standards of care. Recent scrutiny regarding patient treatment practices underscores the importance of maintaining trust and transparency. On the opportunity side, the growing demand for mental health and addiction treatment services presents significant potential for long-term growth, particularly as societal stigmas around these issues continue to diminish.

Conclusion

Acadia Healthcare stands as a key player in the behavioral healthcare industry, offering essential services that address critical societal needs. Its diversified revenue streams, specialized focus, and expansive operational footprint position it for continued relevance in a rapidly evolving market. However, the company must navigate regulatory challenges and maintain its commitment to ethical, patient-focused care to sustain its market position and reputation.

Rhea-AI Summary
Acadia Healthcare Company, Inc. (ACHC) will release its Q4 and year-end 2023 results on February 27, 2024, followed by a conference call with investors and analysts on February 28, 2024. The live broadcast will be available on the company's website for 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
-
Rhea-AI Summary
Ascension Seton and Acadia Healthcare Announce Joint Venture to Expand Behavioral Healthcare in Austin, Texas - ASCN
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
-
Rhea-AI Summary
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) forms a joint venture partnership with Ascension Seton to expand access to behavioral healthcare in Austin and surrounding communities. The partnership will focus on expanding operations at Cross Creek Hospital and constructing a 106-bed expansion of the acute behavioral hospital, increasing the total licensed bed count to 196 upon completion. The new hospital, named 'Cross Creek Hospital together with Ascension Seton,' will be a training site for students, residents, and fellows from Dell Medical School at The University of Texas at Austin. This is Acadia's second joint venture partnership with Ascension, and the company now has 21 joint venture partnerships with premier health systems across the United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
partnership
Rhea-AI Summary
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) will present at the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024, at The Westin St. Francis, San Francisco, California. The webcast of the presentation will be available on the Company’s website starting at 2:15 p.m. Pacific Time/4:15 p.m. Central Time on Tuesday, January 9, 2024, with a replay available for thirty days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
conferences
-
Rhea-AI Summary
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) has opened Coachella Valley Behavioral Health, a state-of-the-art 80-bed hospital in Indio, California. The hospital aims to address the significant need for more accessible, high-quality behavioral healthcare services in the greater Riverside County area. The facility will offer a full continuum of inpatient and intensive outpatient behavioral healthcare services for adults, older adults, and pediatric patients, including comprehensive treatment for those with acute symptoms of general mood disorders, thought disorders, and dual diagnosis/substance use disorders. This new hospital is one of the only freestanding behavioral health hospitals in the region, providing much-needed services that were previously only available at facilities located hours away. The opening of Coachella Valley Behavioral Health aligns with Acadia Healthcare's mission to expand access to behavioral health treatment programs in communities with critical need, not only in California but also across the country.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.77%
Tags
none
-
Rhea-AI Summary
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) will participate in two conferences in November, the Wolfe Research Healthcare Conference 2023 and the Stephens Annual Investment Conference. The live webcast of the presentations will be available on the Company’s website, www.acadiahealthcare.com, with replays available for 30 days.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
conferences
Rhea-AI Summary
Acadia Healthcare Company, Inc. reported a 12.5% increase in revenue for the third quarter of 2023, reaching $750.3 million. Same facility revenue grew by 13.0%, driven by a 6.6% increase in revenue per patient day and a 6.0% increase in patient days. Net loss attributable to Acadia was $217.7 million, while adjusted income was $83.9 million. Adjusted EBITDA increased by 13.4% to $175.9 million. The company made progress in its strategic growth objectives, including facility expansions, de novo facilities, joint ventures, acquisitions, and expanding its continuum of care. Acadia has a strong financial position with $99.6 million in cash and cash equivalents and $520 million available under its revolving credit facility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
-
Rhea-AI Summary
ECU Health and Acadia Healthcare have started construction on a state-of-the-art, 144-bed behavioral health hospital in Greenville, North Carolina. The hospital, slated to open in Spring 2025, will offer comprehensive inpatient and intensive outpatient treatment for mental health disorders. It will also serve as a teaching hospital and address the shortage of clinical behavioral healthcare professionals in the area. The hospital will include 24 inpatient beds specifically for children and adolescents, the first of their kind in ECU Health's service area.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
none
-
Rhea-AI Summary
Acadia Healthcare Company, Inc. has appointed Dr. Patrice A. Harris, MD, MA to its Board of Directors. Dr. Harris, a board-certified psychiatrist, brings significant expertise in mental health and substance abuse. Her experience in healthcare policy and practice will contribute to Acadia's growth as a leading behavioral healthcare services provider.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
none
Rhea-AI Summary
Acadia Healthcare Company, Inc. to release Q3 2023 results on November 2, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.3%
Tags

FAQ

What is the current stock price of Acadia Healthcar (ACHC)?

The current stock price of Acadia Healthcar (ACHC) is $29.68 as of March 5, 2025.

What is the market cap of Acadia Healthcar (ACHC)?

The market cap of Acadia Healthcar (ACHC) is approximately 2.8B.

What services does Acadia Healthcare provide?

Acadia Healthcare offers inpatient and outpatient behavioral health services, including psychiatric care, addiction treatment, and therapeutic programs.

How does Acadia Healthcare generate revenue?

The company generates revenue through its network of healthcare facilities, with payments from Medicaid, commercial insurers, and the NHS.

Where does Acadia Healthcare operate?

Acadia operates approximately 225 facilities across 37 U.S. states, the United Kingdom, and Puerto Rico.

What makes Acadia Healthcare unique in its industry?

Acadia specializes in behavioral health and addiction treatment, offering a wide range of services tailored to different patient demographics.

What challenges does Acadia Healthcare face?

The company faces challenges such as regulatory scrutiny, maintaining high standards of care, and competition from other healthcare providers.

Who are Acadia Healthcare’s primary payors?

In the U.S., Medicaid and commercial insurers are the primary payors, while in the U.K., the NHS accounts for most payments.

What opportunities exist for Acadia Healthcare’s growth?

Growing demand for mental health and addiction treatment services presents significant opportunities for Acadia’s long-term growth.

How does Acadia address patient needs across different demographics?

Acadia tailors its services to specific groups, including children, teenagers, and adults, through specialized facilities and programs.
Acadia Healthcar

Nasdaq:ACHC

ACHC Rankings

ACHC Stock Data

2.83B
90.34M
3.11%
107.65%
6.37%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
Link
United States
FRANKLIN